PR-104 in Treating Patients With Advanced Solid Tumors
Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
Interventions
- DRUG: PR-104
- OTHER: laboratory biomarker analysis
- OTHER: pharmacological study
Sponsor
Proacta, Incorporated
Collaborators